ArticleFrontiers in veterinary science2026
Comparative evaluation of trimethoprim-sulfonamide ratios and synergistic interactions against porcine respiratory pathogens.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Potentiated sulfonamides are widely used in the treatment of porcine respiratory disease complex, but their synergistic activity depends on pathogen-related and pharmacodynamic factors, including the trimethoprim-to-sulfonamide ratio. This study aimed to systematically evaluate the effect of different ratios on in vitro antibacterial interactions against major porcine respiratory pathogens. Methods: Trimethoprim was combined with sulfamethoxazole, sulfachloropyridazine, or sulfadiazine at four mass ratios (1:5, 1:10, 1:19, 1:40). Minimum inhibitory concentrations were determined using broth microdilution according to CLSI guidelines. Drug interactions were quantified using the fractional inhibitory concentration index, and a linear mixed-effects model was applied to assess the effects of bacterial species, compound combination, and ratio. Results: The strongest and most consistent synergistic activity was observed at the 1:5 ratio across most pathogen-drug combinations. Increasing the proportion of the sulfonamide generally reduced synergism and occasionally resulted in antagonistic interactions, particularly in Glaesserella parasuis. Differences between sulfonamides were limited, although sulfachloropyridazine showed higher intrinsic activity against Actinobacillus pleuropneumoniae and G. parasuis, and greater efficacy in combination with trimethoprim against Pasteurella multocida. Statistical analysis confirmed significant effects of both drug ratio and combination on interaction outcomes. Discussion: These findings demonstrate that synergism between trimethoprim and sulfonamides is strongly ratio-dependent and cannot be reliably characterized using a single fixed ratio. Ratio-specific evaluation may therefore support more rational antimicrobial use in veterinary medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.